CompletedPhase 3

Effects of Convective Therapies in Dialysis Patients

Italy146 participantsStarted 2003-11

Plain-language summary

Convective therapies have been proposed for improving chronic dialysis patient outcomes, including intradialytic symptomatic hypotension. To evaluate the frequency of sessions with intradialytic symptomatic hypotension in different types and doses of convective therapies compared with low-flux hemodialysis (HD), the investigators performed a multicentre, open-label, randomized controlled trial.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Dialysis patients aged 18-80 years * thrice-weekly HD or HDF for at least 6 months * body weight less or equal to 90 Kg * stable clinical condition * written consent Exclusion Criteria: * infections * malignancies * active systemic diseases * active hepatitis or cirrhosis * unstable diabetes * diuresis higher than 200 ml/24h * dysfunction of vascular access * blood flow rate less than 300 ml/min

What they're measuring

Intradialytic symptomatic hypotension

Timeframe: all dialysis sessions, three per week, for 2 years

Trial details

NCT IDNCT01583309

SponsorA. Manzoni Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-02

View on ClinicalTrials.gov More Uremia trials